Ferrer Successfully Completes a Phase III Clinical Trial in Adult and Paediatric Patients with Impetigo

News   Jun 10, 2013

 
Ferrer Successfully Completes a Phase III Clinical Trial in Adult and Paediatric Patients with Impetigo
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

Bone Cancer Drug Targets Tumors, Spares Other Organs

News

A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

READ MORE

Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors Spread

News

Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE